Comorbidities and medications in Huntington’s disease, Parkinson’s disease and the general population in a US claims database
Objective: This study characterises the comorbidities and symptoms, and treatment patterns of patients with Huntington’s disease (HD) vs patients with Parkinson’s disease (PD) vs the…Are Cognitive Changes in Hereditary Spastic Paraplegias Restricted to Complicated Forms?
Objective: We aimed to characterize cognitive functions of patients with pure and complicated HSP, and to determine the frequency of abnormal cognitive performances in the…Metabolic syndrome and insulin resistance in Parkinson’s disease: could they affect motor or cognitive symptoms?
Objective: The objective of this work was to detect the markers of metabolic syndrome and insulin resistance in patients with PD and to study their…Predicting domain specific cognitive impairment in Parkinson’s disease
Objective: To investigate whether between-hippocampal connectivity and CSF proteins can predict domain-specific cognitive impairment in Parkinson’s disease (PD). Background: Cognitive dysfunction is a common and…An external relative to an internal focus of attention enhances motor learning in children with poor motor imagery ability
Objective: The purpose of the current study was to examine the effects of an external relative to an internal focus of attention on motor skill…Cardiovascular autonomic function and MCI in Parkinson’s disease
Objective: To evaluate the association between cardiovascular dysautonomia and Mild Cognitive Impairment (MCI) in Parkinson’s Disease (PD) patients. Background: Dysautonomic dysfunction and cognitive impairment represent…Neurocognitive changes post-bilateral globus pallidus interna DBS for Parkinson’s disease with autologous sural nerve graft to the substantia nigra or nucleus basalis of Meynert
Objective: To determine cognitive safety of globus pallidus interna (GPi) deep brain stimulation (DBS) in Parkinson’s disease (PD) patients receiving autologous sural nerve grafts to…The interplay between cholinergic activity, attention, and turning in Parkinson’s disease
Objective: Explore how cholinergic activity (measured by short latency afferent inhibition [SAI]) and attention relate to quality of turning performance over a week of daily…Relationship between cognitive performance and mobility in patients with Parkinson´s disease: A cross-sectional study
Objective: To investigate the relationships between cognitive ability (global and single domain-executive functions) and gait performance (balance, gait speed and mobility) in patients with Parkinson's…Health associated quality of life (HAQL) and humor/cognitive complaints predict mortality in Parkinson’s disease (PD)
Objective: To assess the value of motor (MS), non-motor symptoms (NMS), HAQL and activities of daily living (ADL) for predicting mortality in PD. Background: Parkinson’s…
- « Previous Page
- 1
- …
- 79
- 80
- 81
- 82
- 83
- …
- 141
- Next Page »